Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prospects for PARG inhibitors in cancer therapy.

Autor: Hu Y; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China., Meng Y; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China., Zhuang Z; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.; School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences (UCAS), Hangzhou 310024, China., Li Y; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China., Nan J; College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China., Xu N; Institute of Drug Development & Chemical Biology, College of Pharmaceutical Science, Zhejiang University of Technology, Huzhou 313200, China., Ye Z; Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HlM), Chinese Academy of Sciences, Hangzhou 310022, China.; Zhejiang Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Hangzhou 310022, China., Jing J; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.; Zhejiang Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Hangzhou 310022, China.

Publikováno v: Journal of molecular cell biology [J Mol Cell Biol] 2024 Dec 12. Date of Electronic Publication: 2024 Dec 12.